1. Home
  2. QURE vs LINC Comparison

QURE vs LINC Comparison

Compare QURE & LINC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QURE
  • LINC
  • Stock Information
  • Founded
  • QURE 1998
  • LINC 1946
  • Country
  • QURE Netherlands
  • LINC United States
  • Employees
  • QURE N/A
  • LINC N/A
  • Industry
  • QURE Biotechnology: Pharmaceutical Preparations
  • LINC Other Consumer Services
  • Sector
  • QURE Health Care
  • LINC Real Estate
  • Exchange
  • QURE Nasdaq
  • LINC Nasdaq
  • Market Cap
  • QURE 725.4M
  • LINC 729.2M
  • IPO Year
  • QURE 2007
  • LINC 2005
  • Fundamental
  • Price
  • QURE $14.28
  • LINC $22.65
  • Analyst Decision
  • QURE Strong Buy
  • LINC Strong Buy
  • Analyst Count
  • QURE 10
  • LINC 4
  • Target Price
  • QURE $37.20
  • LINC $24.00
  • AVG Volume (30 Days)
  • QURE 1.2M
  • LINC 290.2K
  • Earning Date
  • QURE 07-31-2025
  • LINC 08-07-2025
  • Dividend Yield
  • QURE N/A
  • LINC N/A
  • EPS Growth
  • QURE N/A
  • LINC N/A
  • EPS
  • QURE N/A
  • LINC 0.39
  • Revenue
  • QURE $20,201,000.00
  • LINC $454,204,000.00
  • Revenue This Year
  • QURE N/A
  • LINC $13.59
  • Revenue Next Year
  • QURE $278.91
  • LINC $8.08
  • P/E Ratio
  • QURE N/A
  • LINC $58.40
  • Revenue Growth
  • QURE 6.30
  • LINC 15.24
  • 52 Week Low
  • QURE $3.73
  • LINC $11.22
  • 52 Week High
  • QURE $19.18
  • LINC $24.20
  • Technical
  • Relative Strength Index (RSI)
  • QURE 47.07
  • LINC 52.60
  • Support Level
  • QURE $13.65
  • LINC $22.32
  • Resistance Level
  • QURE $14.46
  • LINC $24.08
  • Average True Range (ATR)
  • QURE 0.78
  • LINC 0.88
  • MACD
  • QURE -0.18
  • LINC -0.09
  • Stochastic Oscillator
  • QURE 27.21
  • LINC 52.81

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

About LINC Lincoln Educational Services Corporation

Lincoln Educational Services Corp provides diversified career-oriented post-secondary education to high school graduates and working adults. The company offers programs in automotive technology, skilled trades, healthcare services, hospitality services, and business and information technology. Its reportable segments include; Campus Operations, and Transitional. The majority of the revenue is generated from the Campus Operations segment which includes all campuses that are continuing in operation and contribute to the Company's core operations and performance.

Share on Social Networks: